Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Falchi, L; Hutchings, M; Carlo-Stella, C; Morschhauser, F; Dickinson, M; Cartron, G; Khan, C; Tani, M; Martinez-Lopez, J; Bartlett, NL; Salar, A; Brody, JD; Lepp&#228;, S; Berthier, A; Kallemeijn, M; Relf, J; Tchaleu, FB; Lundberg, L; Bachy, E

Author(s): Falchi, L; Hutchings, M; Carlo-Stella, C; Morschhauser, F; Dickinson, M; Cartron, G; Khan, C; Tani, M; Martinez-Lopez, J; Bartlett, NL; Salar, A; Brody, JD; Leppä, S; Berthier, A; Kallemeijn, M; Relf, J; Tchaleu, FB; Lundberg, L; Bachy, E;
Details: Publication Year 2025-04-01,Volume 110,Issue #4,Page 999-1004
Journal Title: Haematologica
Publication Type: Research article
Publisher: Ferrata-Storti Foundation
Department(s): Haematology
Publisher's Version: https://doi.org/10.3324/haematol.2024.286257
Open Access at Publisher's Site: https://doi.org/10.3324/haematol.2024.286257
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-12-12 03:22:30

Last Modified: 2025-05-08 07:28:35